Søren Møller

Søren Møller

Clinical Professor

Member of:

  • Clinical Physiology and Nuclear Medicine


  1. 2018
  2. Published

    Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis: a randomized trial

    Kimer, N., Pedersen, J. S., Tavenier, J., Christensen, J. E., Busk, T. M., Hobolth, L., Krag, A., Abu Al-Soud, W., Mortensen, M. S., Sørensen, Søren Johannes, Møller, Søren & Bendtsen, Flemming, Jan 2018, In: Journal of Gastroenterology and Hepatology. 33, 1, p. 307-314 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis

    Praktiknjo, M., Lehmann, J., Nielsen, M. J., Schierwagen, R., Uschner, F. E., Meyer, C., Thomas, D., Strassburg, C. P., Bendtsen, Flemming, Møller, Søren, Krag, A., Karsdal, M. A., Leeming, D. J. & Trebicka, J., 2018, In: Hepatology Research. 2, 2, p. 211-222 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome

    Wiese, S., Hove, Jens Dahlgaard, Mo, S., Mookerjee, R. P., Petersen, C. L., Vester-Andersen, M. K., Mygind, N. D., Goetze, J. P., Kjær, Andreas, Bendtsen, Flemming & Møller, Søren, 2018, In: Liver International. 38, 9, p. 1614-1623

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial

    Kimer, N., Gudmann, N. S., Pedersen, J. S., Møller, Søren, Nielsen, M. J., Leeming, D. J., Karsdal, M. A., Møller, H. J., Bendtsen, Flemming & Grønbæk, H., 2018, In: PLoS ONE. 13, 9, 12 p., e0203200.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

    Danielsen, K. V., Wiese, S., Hove, Jens Dahlgaard, Bendtsen, Flemming & Møller, Søren, 2018, In: Digestive Diseases and Sciences. 63, 5, p. 1355-1362 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis

    Møller, Søren & Bendtsen, Flemming, 2018, In: Liver International. 38, 4, p. 570-580

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    Total bile acid levels are associated with left atrial volume and cardiac output in patients with cirrhosis

    Voiosu, A. M., Wiese, S., Voiosu, T. A., Hove, Jens Dahlgaard, Bendtsen, Flemming & Møller, Søren, 2018, In: European Journal of Gastroenterology and Hepatology. 30, 4, p. 392-397 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis

    Busk, T. M., Bendtsen, Flemming, Poulsen, J. H., Clemmesen, J. O., Larsen, F. S., Goetze, Jens P. , Iversen, J. S., Jensen, M. T., Møgelvang, R., Pedersen, E. B., Bech, J. N. & Møller, Søren, 2018, In: American Journal of Physiology: Gastrointestinal and Liver Physiology. 314, 2, p. G275-G286 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Validation of non-invasive haemodynamic methods in patients with liver disease: the Finometer and the Task Force Monitor

    Brittain, J. M., Busk, T. M. & Møller, Søren, 2018, In: Clinical Physiology and Functional Imaging. 38, 3, p. 384-389 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 920356